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the context of intermittent access to sugar. These behaviours 
likely arise from intermittent access to sweet tasting or highly 
palatable foods, not the neurochemical effects of sugar.
Conclusion Given the lack of evidence supporting it, we argue 
against a premature incorporation of sugar addiction into the 
scientific literature and public policy recommendations.
Keywords Sugar addiction · Obesity · Binge eating · 
Animal neuroscience · Drug addiction
Introduction
Between 1980 and 2013, the proportion of overweight 
(body mass index (BMI) ≥ 25 kg/m−2) and obese 
(BMI ≥ 30 kg/m−2) adults rose from 28.8 to 36.9 % world-
wide, with similar trends appearing in children and adoles-
cents [1]. The accompanying costs of health consequences 
and absenteeism associated with excess weight, estimated 
to range from $3.38 to 6.38 billion annually in the USA 
alone, make obesity a pressing public health problem [2]. 
The scale and impact of the obesity pandemic are incontro-
vertible. The gravity of the situation demands extreme care 
and careful scrutiny of existing evidence rather than pre-
mature application of questionable concepts. In this spirit, 
we wish to evaluate sugar addiction because such a concept 
could have remarkable consequences in terms of public 
policy and health advice if generally accepted.
The food addiction (FA) model asserts that excessive 
consumption of palatable foods may be understood within 
the same neurobiological framework as drug addiction. The 
model of addiction here is that operationalised in the Diagnos-
tic and Statistical Manual of Mental Disorders (DSM-IV) and 
one that is widely accepted in the neuroscientific literature. 
It is characterised by loss of control of drug consumption, 
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increased motivation to consume, and a persistence of drug 
taking despite negative consequences, and the neurobiology 
of these behaviours has been extensively studied (see [3, 4]). 
Individuals who develop FA are thought to display symptoms 
analogous to those of drug abuse, including loss of control, 
withdrawal, and cravings for ‘problem foods’ [5]. Theron 
Randolph first used the term ‘food addiction’ in 1956 [6] to 
describe addictive-like consumption of various foods, such 
as corn, milk, eggs, and potatoes. However, aspects of the 
FA model have changed since this original description (see 
[7]), and there is an emerging view that highly processed 
foods, rich in sugar and fat, are most likely to be addictive. 
FA researchers argue that examining obesity through the lens 
of addiction will open new avenues for prevention, treatment, 
and public health policy [8, 9] though this, like many other 
aspects of the model, has been questioned [10, 11].
Sugar addiction represents a specific case of the FA 
model in which the addictive substance is the specific nutri-
ent sugar. In this perspective article, we consider the state 
of the evidence in support of sugar addiction in humans 
and provide a critical review of the preclinical neurosci-
ence research that has identified sugar addiction in rodent 
models. This is important because few studies have specifi-
cally examined sugar addiction in humans, and the bulk of 
supporting evidence comes from animal work. However, 
there is a methodological challenge in translating this 
work because humans rarely consume sugar in isolation. 
In order to assess the existing evidence, we must first con-
sider whether sugar could be an addictive agent, examining 
specifically the animal neuroscientific evidence suggested 
to support this. As the animal neuroscience of sugar addic-
tion draws strong parallels to drug addiction, we review 
the sugar and drug addiction neuroscience side by side. 
We go on to consider the human model of FA to determine 
whether and how it could be applied to sugar.
Characterising (potentially) addictive foods
A general view is that FA is similar to substance addictions, 
rather than non-substance behavioural addictions outlined 
in the Diagnostic and Statistical Manual of Mental Disor-
ders, 5th Edition (DSM-5, for a different perspective, see 
[12]), in that certain ‘addictive agents’ within food produce 
neurochemical effects in the brain similar to drugs of abuse. 
The Yale Food Addiction Scale (YFAS [13] and recently 
the YFAS 2.0 [14]), which is now the widely accepted 
measurement tool for studying FA, enquires about addic-
tion-like eating behaviours with respect to ‘certain foods’. 
These scales do not specify nutrients of interest, yet this is 
only reasonable as we usually consume food with multi-
ple nutrients. Even foods that may be predominantly com-
posed of a single nutrient (e.g. sugar-sweetened beverages) 
have flavour(s) and other non-nutritive elements. How-
ever, examining the addictive potential of different foods 
may provide an indication as to whether any particular 
nutrient(s) are critical in determining addictive potential.
Evidence from rodent models supports high-fat [15], 
high-sugar [16], and, most strongly, combinations of high-
fat and high-sugar [17] foods as candidates for FA. In 
humans, the FA construct extrapolates this view, surmising 
that highly processed, hyperpalatable foods are the ones 
that have addictive potential [18]. Lack of knowledge sur-
rounding what might constitute an addictive food poses a 
substantial challenge, and to our knowledge, only two stud-
ies have examined the addictive potential of various foods.
Schulte et al. [5] suggest that certain highly processed 
foods share pharmacokinetic properties (inasmuch as the 
term can be used for food), such as high potency and rapid 
absorption rate, with drugs of abuse. The authors report 
that such processed foods are strongly associated with self-
reported addictive eating as measured by the YFAS. Their 
findings also demonstrate that fat content and glycaemic 
load (GL, grams of carbohydrate per serving) predict ratings 
of problematic foods, where processed foods high in fat and/
or GL are self-reported as more problematic. In this study, 
highly processed foods were defined as those high in fat 
and refined carbohydrates (high GL) that may also contain 
low levels of fibre, protein, and water content. Schulte et al. 
[5] argue that processing of raw foods increases the foods’ 
‘potency’, or the absorption of the potential ‘addictive 
agents’ (e.g. fat, sugar, salt) into the bloodstream, as indexed 
by spikes in blood glucose levels following consumption.
Fowler et al. [19] hypothesised that individuals who 
developed substance use disorders post-bariatric surgery 
would be more likely to have had problems with foods that 
would cause high postprandial glucose levels. For this, they 
used foods listed in the YFAS and categorised them based 
on published glycaemic indices (GI), fat, and sugar content. 
Findings indicated increased likelihood of post-operative 
substance use amongst patients who endorsed high-GI and 
high-sugar, low-fat (but not high-sugar alone) foods as the 
most problematic [19]. Thus, the authors concluded that 
these patients might have experienced ‘addiction transfer’ 
resulting from previously undiagnosed FA. These findings 
should be interpreted in the light of several limitations. Apart 
from the retrospective recall of ‘problem foods’, only two 
foods (candy and soda pop) were classified as high sugar low 
fat. Furthermore, analyses of the relationship between prob-
lem foods and substance use onset failed to control for cur-
rent or previous psychiatric morbidity, success of surgery, or 
current quality of life. Moreover, we would suggest caution 
in arguing that such foods are addictive based on the conten-
tious concept of addiction transfer [20].
To describe the difference between foods such as cup-
cakes and bananas primarily as being one of the degrees 
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of processing is perhaps a rather narrow view, and a strong 
case can be made for these foods having other important 
differences relevant to overconsumption and obesity (e.g. 
energy density). Even leaving this aside, there are several 
important concerns about both of these studies. First, the 
potentially addictive foods have been taken from the ‘prob-
lem foods’ list of the YFAS. The scale quantifies FA symp-
toms with respect to these problem foods, based on the 
assumption that they are likely to be addictive. Both of the 
aforementioned studies rely on this assumption and take 
the evidence that individuals have reported FA symptoms 
with respect to these foods on the YFAS in several studies, 
as further supporting the assumption. Second, these find-
ings rely entirely upon participants’ perceptions of difficul-
ties surrounding the foods items, which are then linked (by 
way of mechanistic explanation not empirical evidence) 
via GL or GI to postprandial glucose and insulin. That is, 
no direct evidence indicates that these foods are problem-
atic for these individuals because they lead to higher post-
prandial glucose. Although individual postprandial glucose 
response (PPGR) has low intra-personal variability, there 
can be high interpersonal variability in PPGR following 
the consumption of identical meals [21, 22]. For example, 
Zeevi et al. [21] found that PPGRs for cookies and bananas 
varied significantly across participants, suggesting that 
some individuals may be high glucose responders to ‘good’ 
foods and low responders to ‘bad’ foods. It is also impor-
tant to note that there are several high-GI foods such as 
breakfast cereals and baked potatoes that are not included 
in the list of YFAS problem foods. This suggests that the 
potential explanatory power of high GI as a determinant of 
addictive potential would lessen considerably if we looked 
beyond the list of problem foods. Given the host of meta-
bolic, endocrine, and physiological factors that affect glu-
cose regulation, it is important to consider the physiologi-
cal response to foods as an interaction between the nutrient 
content of the food and the individual.
Third, and most importantly, the proposed model of why 
high-GI/high-GL foods may be potentially addictive lacks 
a mechanistic link between higher postprandial levels of 
glucose and addictive potential. Schulte et al. draw upon 
a seemingly superficial similarity between the addictive 
potential of drugs, based on their dose and speed of absorp-
tion, to explain why processed foods are likely to be addic-
tive. Proponents of FA draw parallels between the process-
ing of grapes to wine, poppies to opium, and the coca leaf 
to cocaine, which demonstrate the transition from naturally 
occurring substances/food to drugs of abuse and increasing 
potency via processing. Yet, this formulation of highly pro-
cessed foods only captures the pharmacokinetic aspects of 
drugs of abuse, overlooking the critical pharmacodynamic 
effects. The coca leaf, for instance, has a pharmacodynamic 
effect, which can be enhanced by increasing the dose of 
the active ingredient through processing. For sugar or other 
foods, studies show that moderate increases in blood glu-
cose following oral glucose ingestion can enhance cogni-
tive performance in a variety of tasks, including semantic 
memory retrieval [23], reaction time tasks [24], and even 
driving performance [25]. Few functional MRI studies have 
examined the effect of blood glucose on brain function as 
it relates specifically to hedonic eating behaviours; how-
ever, Sun et al. [26] report that neither fasting nor postpran-
dial blood glucose affected the blood-oxygen-dependent 
(BOLD) response to milkshake taste cues in several brain 
regions (e.g. amygdala, pallidum, insula) that have been 
implicated in drug cue studies. In men, increased post-
prandial blood glucose levels have been associated with 
increased resting state brain activity in regions associated 
with reward processing [27]. Given the tight physiological 
control over the stability of glucose supply to the brain, it 
is perhaps not unexpected that changes in systemic glucose 
would not have large effects on brain function. In short, 
the notion of increased dosage having increased potency 
and therefore increased addictive potential is questionable 
when it comes to sugar.
Is sugar a potentially addictive substance?
The FA literature considers sugar (and other refined car-
bohydrates) to be a key facet of processed foods with high 
addictive potential, contributing to their GL (dose) and 
their rapid rate of absorption. Within this context, discus-
sion of sugar has centred on its palatability or hedonic 
value; however, unlike substances of abuse, sugar has both 
hedonic and caloric value, and these two aspects broadly 
map onto ingestive and post-ingestive effects of its con-
sumption, respectively. Moreover, these aspects are dis-
tinct and dissociable in terms of their neural processing as 
demonstrated in two elegant sets of experiments. Domin-
gos et al. [28] showed that melanin-concentrating hormone 
(MCH)-expressing neurons located within the lateral hypo-
thalamus respond to extracellular glucose levels and project 
to dopaminergic (DA) neurons in the striatum and midbrain 
regions. The animals show a preference for sucrose over 
the non-nutritive sweetener, sucralose, and the glucose-
sensing ability of these neurons is critical in determining 
this, as transgenic mice lacking MCH neurons do not show 
this preference [28]. MCH neurons encode the rewarding 
nutrient properties of sucrose by increasing striatal DA 
release independently of gustatory input. Optogenetic stim-
ulation of MCH neurons during consumption of sucralose 
leads to striatal DA efflux and preference for sucralose over 
sucrose [28].
Recently, Tellez et al. [29] expanded upon this work by 
examining DA transmission in the striatum in response 
to oral sucralose intake versus intra-gastric glucose or 
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sucralose administration. Using microdialysis, the authors 
reported changes in DA release in the ventral and dorsal 
striatum, where regional DA release selectively encoded 
the pleasurable and nutritional value of the sweet foods. 
Sucralose consumption was linked to enhanced DA efflux 
in the ventral striatum (VS), which was no longer observed 
following devaluation of the sweetener with a bitter addi-
tive. Conversely, intra-gastric infusion of glucose, but not 
sucralose, elicited DA release in the dorsal striatum (DS). 
Thus, the VS and DS appear to encapsulate functionally 
distinct responses to palatable and nutritive signalling, and 
the authors went on to delineate the role of D1 and D2 stri-
atal DA neurons in palatability and nutrient preferences. 
Dopaminergic signalling excites D1 DA neurons while 
inhibiting their D2 DA counterparts, and this interaction 
modulates the control of goal-directed actions, including 
overeating [17]. Optogenetic stimulation of D1 DA neurons 
within the DS and substantia nigra terminals increases con-
sumption of a bitter sucrose solution, which supports the 
dorsal basal ganglia pathway as a circuit that is selectively 
responsive to the nutrient properties of sugar reward [29]. 
It should be noted, however, that the role of MCH, D1 DA, 
and D2 DA neurons has yet to be explored in animal mod-
els of sugar addiction, so whether the aforementioned neu-
ral circuits reflect processes underlying addictive-like sugar 
consumption remains unknown.
This experimental work allows us to consider that addic-
tive-like properties of sugar may occur via three neural 
mechanisms: one related to palatability and the reinforcing 
effects of sweet taste, another related to caloric value and 
post-ingestive effects, and a third arising from a combina-
tion of the two effects. Put simply, the critical ‘addictive’ 
quality of sugar may be restricted to its sweetness, nutri-
tional value, or some combination of the two. Of course, 
only the third possibility would support sugar as addictive, 
particularly within Schulte et al.’s model where highly pro-
cessed foods with added sugar would be very sweet, energy 
dense, and rapidly absorbed and therefore potentially 
have a characteristic profile of ingestive and post-inges-
tive effects. Nonetheless, as humans often consume sugar 
in combination with other nutrients, differences between 
highly processed foods with high and low addictive poten-
tial would need to be characterised. Indeed, Zeevi et al. [21] 
demonstrated that the same foods can have very different 
post-ingestive profiles in different individuals. This may be 
a critical factor and one aspect of individual vulnerability 
to a potentially addictive food. These are theoretical con-
siderations as thus far little work in humans has examined 
them directly. The animal literature does, however, offer 
some experimental evidence of parallels between sugar and 
drugs. We consider this in the next section, beginning with 
a brief overview of the neurobiological characteristics of 
drug addiction.
Animal models of drug addiction
Prevailing models of drug addiction emphasise changes 
in reward-based learning and memory processes as core 
mechanisms involved in the transition from voluntary 
drug use to chronic abuse. Initially, goal-directed drug use 
releases DA within the mesolimbic system which rein-
forces ‘drug-taking’ behaviour by increasing the salience 
of, and subsequent motivation towards, drug-related cues 
[30]. Drug taking increases DA in the nucleus accumbens 
(NAcc) shell, yet this response becomes blunted over time 
in a manner that differs from habituation [31]. Instead, 
drug-related cues produce an anticipatory DA release in 
the DS, resulting in strong drug cravings [32]. This has 
been framed as an increased anticipatory reward with an 
attenuated consummatory reward. Activation in the dorsal 
striatum and basolateral amygdala drives ‘drug-seeking’ 
behaviour, and as this behaviour becomes increasingly 
elicited by drug-related cues, it is ultimately consolidated 
as a stimulus–response (S–R) habit [33]. This transition 
from goal-directed to habitual drug taking has been studied 
extensively (see [3, 34]) in rodent models of addiction to 
cocaine, heroin, and alcohol and strongly resembles com-
pulsive drug use in humans. These compulsive behaviours 
arise from functional impairment in the prefrontal cortex 
(increased drug salience, compulsivity), as well as the dor-
solateral and inferior cortices (compromised executive con-
trol) [35].
The onset of drug addiction has been associated 
with decreased availability of DA D2 receptors in both 
humans and non-human primates [36, 37]. These findings 
relate low DA receptor availability to increased trait vul-
nerability to drug abuse; however, it has been argued that 
chronic drug use reduces the number of DA D2 recep-
tors, thus resulting in a ‘hypodopaminergic’ system [38]. 
While it is likely that aberrant DA D2 receptor numbers 
reflect both cause (trait vulnerability to) and consequence 
of prolonged drug use, reduced DA D2 receptor avail-
ability has been closely tied to withdrawal symptoms 
and the development of drug tolerance, in which drug 
consumption no longer elicits a positive effect but rather 
mitigates a negative state [39, 40]. Together with afferent 
input from the amygdala, these neuronal changes in the 
striatum (i.e. reduced DA D2 receptors) perpetuate drug 
use to avoid dysphoria and withdrawal, comprising what 
Koob and Le Moal [41] have termed the ‘dark side’ of 
addiction.
Accordingly, in sugar addiction, one could expect to 
see a similar behavioural and neurobiological syndrome. 
Voluntary consumption of sugar under goal-directed con-
trol would increase DA release in the mesolimbic sys-
tem, enhancing the salience of and motivation for sugar. 
Over time, sugar seeking and consumption would become 
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habitual and compulsive with an accompanying shift from 
ventral to dorsal striatal control, as well as changes in pre-
frontal cortical control of these behaviours. These neural 
adaptations would serve to perpetuate sugar seeking that 
may also be driven by the need to avoid withdrawal symp-
toms. In line with research of chronic drug use, DA D2 
receptor levels may represent a vulnerability marker and 
also result as a consequence of excessive sugar intake over 
time, regardless of BMI status or obesity.
Comparison of drug addiction and sugar addiction
Critical to these studies are the experimental designs used 
to model addiction-like behaviours in rodents. We believe 
that a working knowledge of these paradigms and their 
limitations is necessary to critically examine the literature 
on animal models of drug and sugar addiction. Thus, this 
section will provide an overview of common paradigms, 
and we will compare different aspects of drug and sugar 
addiction within this context. Comparisons have been 
drawn between sugar and a variety of illicit drugs, but for 
the purpose of this perspective article, we have chosen to 
focus on the neurobiological effects of cocaine, a stimulant 
that ‘hijacks’ the dopaminergic system, and heroin, an opi-
ate that acts upon both dopaminergic and endogenous opi-
oid systems. It is important to point out at the outset that 
sugar addiction literature is not as extensive as that of drug 
addiction literature, and therefore, not all aspects of addic-
tion have been examined with respect to sugar.
General overview of experimental models
Drugs
Rodent models of addiction traditionally frame the drug 
of choice as a positive reinforcer, which becomes associ-
ated with a pleasurable outcome. A drug is thought to 
function as a positive reinforcer if the animal’s response 
to the agent exceeds the response to a control, e.g. saline 
solution. Typically, animals are trained to self-administer 
the drug for a short daily session of 1 to 3 h [42] for 10 
to 30 days [43]. For example, rodents may be trained to 
self-administer intravenous (IV) cocaine via a lever press 
or nose poke using a low ratio requirement where each 
lever press prompts drug delivery (a fixed ratio 1 (FR1) 
delivery). Drugs can be administered orally or intrave-
nously, though it is often preferred to use the route most 
analogous to drug use in humans while taking into consid-
eration taste effects. Thus, implanted catheters are usually 
used for IV infusion of cocaine and heroin, but some stud-
ies allow access to an oral cocaine–sucrose solution [44, 
45]. It should be noted that, because many protocols train 
rodents to self-administer drugs of abuse prior to testing, 
this approach is insufficient to quantify vulnerability to 
drug addiction. As such, the use of drug-naïve animals has 
become increasingly commonplace.
To model the transition to compulsive ‘drug seeking’, 
the rodents are moved to progressive ratio (PR) tasks, in 
which they must systematically work harder (i.e. increase 
the number of lever presses for a single infusion). Moti-
vation is further measured by ‘breakpoints’, or the ratio 
at which the animal is no longer willing to work for the 
reward, and it can be augmented by periods of drug absti-
nence. To examine the degree to which the animal will 
work for the drug despite negative consequences—a key 
feature of drug dependence—the conditioned stimuli (e.g. 
lever press) or outcomes are paired with aversive outcomes, 
such as an electric footshock or nauseating chemical addi-
tive. Following extensive drug self-administration, rodents 
display withdrawal symptoms in response to forced absti-
nence, as well as dopamine (e.g. sulpiride) and opioid (e.g. 
naloxone) antagonists. However, drug seeking can be extin-
guished throughout periods of forced deprivation by replac-
ing the cocaine or heroin infusion with saline (for a com-
plete review, see [46]).
In human addiction, habitual drug-seeking and drug-
taking behaviour, even following sustained abstinence, is 
often elicited by environmental cues, acute stress, or drug 
exposure. Second-order reinforcement schedules represent 
one method by which cue-elicited reinstatement of drug 
seeking can be studied in animals [47]. The drug infu-
sion is paired with an additional conditioned stimulus (e.g. 
illuminated light, tone) following which exposure to the 
conditioned stimulus has been shown to reinstate cocaine-
seeking behaviour [48] and morphine administration [49] 
following abstinence. More recently, the conditioned place 
preference (CPP) paradigm has become a widely used 
design, in which rodents associate distinct environments 
with drug and saline infusions. Following abstinence, re-
exposure to these environments, along with drug priming, 
leads to the reinstatement of habitual cocaine and heroin-
seeking behaviour [50], thus modelling the circumstances 
under which humans often experience drug relapse.
Sugar
Although sugar (e.g. sucrose, saccharin, glucose) reinforce-
ment has been widely used as a natural reward control 
within drug addiction studies, Avena et al. [16] have dem-
onstrated that, under certain conditions, rats can develop 
addiction-like behaviours with respect to sugar. After over a 
decade of sugar addiction research, Hoebel et al. [51] claim 
to, ‘[…] still use the same basic technique to obtain clear 
signs of food dependency by imposing a feeding schedule 
that repeatedly induces sugar bingeing after a period of 
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fasting’. In brief, this technique deprives rodents of food 
for 12 h (or in some instances, 16 h [52]) and permits free 
access to food for the subsequent 12 h, during which the 
rats may consume either chow or a sugar solution. Sugar is 
offered as either a 25 % glucose solution or a 10 % sucrose 
solution; the latter simulates a soft drink. For intermittent 
sugar access, the 12-h period of food availability begins 4 h 
into the dark cycle so as to increase rodents’ appetite and 
therefore the likelihood of consuming a novel food [51]. 
An important difference between the animals included in 
these experiments is that unlike the drug models, which 
increasingly use drug-naïve animals, these animals have 
usually had previous access to sucrose and are selected for 
sucrose preference (e.g. [53]). This raises the possibility 
of these animals having a vulnerability to developing this 
addiction-like syndrome. Rodents kept on this schedule for 
3 to 4 weeks begin to develop signs of addiction, which we 
review below (see [54] for additional review). It is impor-
tant to emphasise these addiction-like behaviours are only 
seen with sugar with intermittent access regimes and not 
with ad libitum access.
Bingeing
Drugs
Following initial self-administration training, increased 
access (e.g. 6 h/day) to cocaine and heroin has been asso-
ciated with enhanced, binge-like consumption [55–57]. 
Rodents with extended access to a low-dose cocaine infu-
sion develop a binge-like pattern of consumption that 
increases rapidly at the outset, plateaus, and becomes 
highly variable after 24 h, where increased time between 
binges may serve to counteract the drug’s toxic effects 
[58]. Interestingly, binge-like self-administration of heroin 
may be moderated by satiety as food-restricted rodents 
self-administer the most heroin at the start of the session, 
but fed rodents self-administer heroin at a low, stable level 
throughout the session [57]. The reinforcing effects of both 
cocaine and heroin are dose dependent, and moderate doses 
have been shown to elicit reinforcing effects without lead-
ing to drug dependence [59].
Acute IV administration of cocaine preferentially 
increases extracellular DA in the NAcc shell when com-
pared to the NAcc core [60], and this is associated with the 
acute reinforcing effects of cocaine. Heroin, too, increases 
DA release in both the ventral tegmental area (VTA) and 
the NAcc shell; however, this begins with the activation of 
mu-opioid receptors (MOR), which triggers a neurochemi-
cal cascade that leads to increased mesolimbic DA release 
[61, 62]. Mesolimbic DA release elicits hyperactivity and 
euphoric effects following cocaine and heroin infusion, 
respectively. These effects can be inhibited (as evidenced 
by reduced self-administration) by lesions to the ventral 
pallidum, as well as D1 receptor blockade in the central 
nucleus of the amygdala, in cocaine-conditioned animals 
[63, 64]. As heroin has high affinity for MOR and delta 
opioid receptors (DOR), administration of selective MOR 
and DA agonists has been shown to result in heroin rein-
forcement that is extinguished following chemical lesion-
ing of DA neurons or microinjections of opioid receptor 
antagonists within the VTA [65].
Sugar
Binge-like sugar consumption has been observed in rodents 
under both 24-h and intermittent reinforcement sched-
ules, where animals self-administer sugar on an FR1 pro-
tocol. Colantuoni et al. [66] reported that food-deprived 
rats increased sugar intake within the first hour of access 
to food, and similar bingeing patterns occur when rats 
receive 12-h access to both sugar and chow [51]. With 
the same intermittent reinforcement schedule, sham-fed 
rodents consume more sucrose than real-feeding controls 
[67], although differences are non-significant with repeated 
consumption. Interestingly, rodents with ad libitum access 
to sugar solution consume the food throughout the light 
phase (or inactive cycle), and total sugar intake does not 
differ between rodents with 12- versus 24-h access [16]. 
Moreover, rats fed daily intermittent sugar and chow offset 
sugar consumption by decreasing chow consumption, thus 
regulating caloric intake and preventing weight gain [68, 
69]. Because rodents with ad libitum sugar access offset 
caloric intake and meal size throughout the testing period, 
Avena et al. [16] concluded that such experimental condi-
tions cannot elicit sugar dependence. As such, it appears 
that the intermittent access is critical to the development of 
binging, as animals provided ad libitum access to sucrose 
fail to develop addictive behaviours. With respect to obe-
sity, it is worth emphasising that rats on both intermittent 
and ad libitum access schedules offset chow intake to com-
pensate for their sucrose intake and to maintain weight 
stability.
These behavioural data highlight noteworthy differences 
between sugar and drug bingeing. An immediately appar-
ent distinction arises from temporal discrepancies related to 
forced deprivation of sugar versus drugs of abuse. Despite 
limited evidence of food restriction increasing vulner-
ability to chronic cocaine use [70], rodents increase both 
cocaine and heroin intake under normal feeding conditions, 
or those which maintain rodents at 85 % body weight (e.g. 
[71]). Under such conditions, it is possible to delineate 
the reinforcing effects of drugs of abuse versus non-drug 
rewards; however, these processes become conflated when 
sugar is only presented following food restriction. As simi-
lar findings are seen in sham-fed rats, it suggests that sugar 
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bingeing results from the reinforcing effects of a preferred 
flavour, rather than post-ingestive effects of sucrose [54]. 
Under ad libitum conditions, rats dramatically increase 
cocaine intake initially, and, although bingeing becomes 
variable, rats continue to binge throughout the 72-h period 
[58]. Minimal restriction of cocaine self-administration has 
led to bingeing patterns that converge with an inherent cir-
cadian rhythm, as rodents repeatedly refused to self-admin-
ister cocaine during the light phase [72]. Yet, binge-like 
consumption of sugar appears to follow a distinct con-
summatory pattern with binges occurring early in the food 
available period, which likely arises from both homoeo-
static regulation of feeding behaviour and the presence of 
palatable food.
The neurobiology of sucrose reinforcement has largely 
focused on dopaminergic effects in the NAcc shell and core. 
Intermittent sucrose consumption persistently increases 
extracellular DA in the NAcc shell and core in response to 
sugar in both sham [67] and normal feeding [16, 52] sched-
ules. This effect does not appear in either control or ad libi-
tum sugar access animals, and as with most foods, the DA 
response to sugar quickly habituates [73, 74]. Thus, a drug-
like DA response to sugar is only observed in the intermit-
tent binging paradigm, suggesting a critical role of the par-
adigm. Corwin has raised the possibility that this paradigm 
promotes a form of eating under uncertainty because food 
availability is unpredictable [75, 76].
Infusion of a selective mu-opioid agonist into the 
NAcc has led to increased consumption of sweet foods 
(e.g. chocolate) with identical nutrient profiles, suggest-
ing that increased mu-opioid receptor binding underpins 
flavour rather than sucrose preference [77]. Additionally, 
MOR agonism in the NAcc has enhanced saccharin intake 
[78]. Infusion of naltrexone (an opioid antagonist with 
high MOR affinity) directly into the NAcc decreased con-
sumption of the preferred flavour, yet systemic injection 
decreased consumption of both foods equally. These find-
ings, along with those of Tellez et al., demonstrate distinct 
neural mechanisms for sweetness and caloric content, 
and support the role of rewarding effects of sweet taste in 
this intermittent access paradigm. Benton [54] and Dile-
one et al. [79] have previously argued the post-ingestive 
properties of glucose appear to have little effect on ini-
tial consolidation of its rewarding properties. Moreover, 
neurobiological changes in the striatum have yet to be 
reported in the absence of the intermittent sugar binging 
(i.e. with ad libitum access to sugar) [66]. In summary, 
the dopaminergic changes that resemble addiction only 
occur with sugar consumption under the intermittent 
access regime, and without these conditions, the dopa-
minergic response to sugar resembles that to other natu-
ral rewards. Conversely, cocaine and opiate drugs cause 
neurobiological changes within the NAcc and VS that 
lead to and perpetuate addiction, including changes in D2 
DA receptor levels [3] and MOR density and expression 
[80] following chronic cocaine and opiate administration, 
respectively.
Motivation and substance seeking
Drugs
Following initial self-administration training, rodents show 
increased motivation for cocaine self-administration as evi-
denced by high breakpoints within PR schedules. Break-
points may be manipulated by several experimental param-
eters, including the unit injection dose and restricted access 
to cocaine. For example, rats that were allowed access to 
cocaine 4 times/h in a 24-h period during initial self-admin-
istration showed higher breakpoints after 7 days of absti-
nence when compared to rats that were initially allowed 
72-h access [81]. Roberts et al. [55] assert that a progres-
sive increase in daily breakpoints is not only dose depend-
ent, but also moderated by the speed of the injection. For 
example, in rodents with a history of cocaine use, animals 
that received 3.0 mg/kg doses had significantly higher 
breakpoints than those that received 1.5 mg/kg doses [82]. 
Over several days of testing, speed of initial cocaine infu-
sion significantly altered breakpoints, with higher break-
points observed in rodents receiving cocaine infusions over 
5 s versus those receiving slower infusions (e.g. 25 or 50 s) 
[83].
Unlike cocaine seeking, the emergence of heroin-seek-
ing behaviour is closely tied to the onset of acute with-
drawal symptoms, which result in increased consumption 
by way of negative reinforcement (i.e. avoidance of a dys-
phoric state). Acute opiate exposure increases pain sensi-
tivity, which worsens with chronic use, and sensitisation of 
nociceptive systems may be related to the development of 
drug dependence via negative reinforcement [57, 84]. Both 
forced deprivation and opioid antagonists produce a with-
drawal syndrome characterised by teeth chattering, paw 
tremors, and erratic activity [80].
Cocaine abstinence increases motivation in rodents ini-
tially trained on PR but not FR schedules, suggesting that 
the establishment of cocaine as a positive reinforcer power-
fully enhances drug seeking after abstinence [85]. Moreo-
ver, Vanderschuren and Everitt [71] demonstrated that 
presentation of an aversive footshock does not suppress 
cocaine seeking in rodents with a prolonged cocaine self-
administration history. Importantly, the authors assessed 
drug-seeking behaviour within a heterogeneous seeking–
taking chain schedule, in which seeking and taking cocaine 
are distinct acts with separate levers. Additionally, pairing 
both cocaine–sucrose and lemon–sucrose solutions with an 
aversive lithium chloride injection has been shown to only 
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devalue the lemon–sucrose solution as rodents maintained 
the same level of drug seeking for the cocaine solution [45].
Changes in the limbic, cortical, and ventral striatal cir-
cuitry mediate the development of drug-seeking behav-
iour [34]. Lesioning of either dopaminergic circuitry in 
the basolateral amygdala or glutamatergic circuitry in the 
NAcc core alters cocaine seeking [86]. In contrast, lesion-
ing of medial PFC subregions enhances cocaine seeking 
[87], likely by way of diminished executive control, as 
this region projects to the posterior dorsomedial striatum 
(pDMS) and reciprocally to the basolateral amygdala [34]. 
The DA D2 system appears central to the development of 
enhanced motivation for morphine. Mice lacking D2 DA 
receptors equally pursue morphine and saline infusions on 
FR or PR schedules [88]; however, rodents with increased 
proenkephalin gene expression in the NAcc and DS dem-
onstrate significantly higher breakpoints for morphine 
infusion than wild-type animals [89]. Thus, converging 
neurobiological evidence identifies both dopaminergic and 
opioid systems in the maintenance of opiate seeking. Over 
time, these neurobiological changes lead to the loss of con-
trol over drug seeking and intake, resulting in the hallmark 
feature of addiction—habitual drug seeking.
Sugar
Enhanced motivation and sugar seeking are often achieved 
by forced deprivation, which has increased the number of 
lever presses for self-administration of sucrose solution 
[16]. However, these findings do not directly represent 
rodents’ motivation for a sugar reward but rather the num-
ber of unsuccessful lever presses executed under an FR1 
schedule (i.e. the lever presses in between sugar receipt). 
Receipt of sugar reward was not dependent upon the num-
ber of additional presses between reinforcement. A more 
recent study has incorporated differential reinforcement 
schedules, which systematically increase the time inter-
vals between sucrose reinforcements to quantify impulsive 
responding for sucrose solutions [90]; however, the find-
ings failed to demonstrate increased lever pressing across 
sucrose-reinforced sessions as compared to control (i.e. 
water) sessions. As such, motivation for sucrose appears to 
be less robust than that for either cocaine or heroin, though 
expectedly infusion of a selective mu-opioid agonist signif-
icantly increases break points for sugar pellets in a progres-
sive ratio schedule [91].
Some research has quantified motivation for sucrose by 
direct comparison with other drug-seeking behaviours. In 
one study, some rodents preferred self-administration of 
saccharin over cocaine and paid a greater ‘price’ for sac-
charin than for cocaine by adhering to FR2, FR4, and FR8 
reinforcement schedules [53]. Although this resembles 
early PR schedules in which rodents linearly increased 
lever presses for subsequent infusions, standard PR sched-
ules for drug reinforcement now require rats to increase 
lever presses exponentially from one infusion to the next 
[55]. Thus, direct comparison of these findings to those 
from PR schedules of cocaine and heroin reinforcement 
overestimates the degree to which saccharin increases 
motivation. Rodents bred for high-saccharin selectivity 
increased cocaine consumption following reinstatement 
of drug-seeking behaviour, yet the effect(s) of sweet pref-
erence on vulnerability to drug addiction remain poorly 
understood [92]. For example, preference for Oreo cook-
ies has predicted greater break points on a PR schedule for 
IV cocaine infusion, yet rodents that preferred rice cakes 
demonstrated equivalent self-administration, tolerance, and 
reinstatement of cocaine-seeking behaviour [93].
Habitual use and withdrawal
Drugs
Rodents with extended cocaine self-administration train-
ing preferentially return to environments in which cocaine 
was administered, even following periods of abstinence 
(see [94, 95]). Exposure to the conditioned stimulus (i.e. a 
light previously paired with lever pressing) has been shown 
to reinstate cocaine-seeking behaviour [48] and morphine 
administration [49] following abstinence. A combination 
of drug priming, or drug injections following abstinence, 
and the CPP paradigm restores habitual cocaine and heroin 
[50]-seeking behaviour, thus modelling the circumstances 
under which humans often experience drug relapse.
Whereas the acute reinforcing effects of cocaine are 
associated with increased extracellular DA in the VS and 
NAcc shell, cocaine seeking has been related to enhanced 
DA in the DS independent of the NAcc [96]. Blockade of 
DA receptors in the anterior dorsolateral striatum, but not 
the pDMS or NAcc, decreases drug seeking [97]. Jedynak 
et al. [98] further demonstrated that prolonged stimulant 
use alters synaptic connectivity in DS neurons by increas-
ing dendritic spine density in the dorsolateral subregion 
and decreasing spine density in the dorsomedial subregion. 
The authors assert that such restructuring of synaptic con-
nectivity in the DS underlies the emergence of S–R habits 
following chronic stimulant use as the dorsolateral striatum 
gains control of these behaviours. As discussed above, in 
the case of heroin, the opponent processes model describes 
the persistence of drug use as negatively reinforced by the 
dysphoria of withdrawal symptoms [99].
Sugar
Although compulsive sugar-seeking behaviour follow-
ing extended consumption has yet to be studied explicitly, 
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converging evidence suggests that animals develop CPP 
in response to food rewards. After abstaining from sugar, 
food-deprived rodents prefer the environments in which 
12 and 20 % sucrose solutions were consumed [100, 101], 
and similar findings were reported with high-sucrose food 
rewards [102]. Administration of naltrexone dose-depend-
ently disrupts CPP for sucrose, yet the opioid antagonist 
does not affect the development of CPP [103]. The com-
petitive opioid antagonist naloxone precipitates withdrawal 
symptoms in sugar-bingeing rats, which resemble those of 
opiate withdrawal (e.g. anxiety, teeth chattering, forepaw 
tremor, head shakes) and share a similar neural profile with 
decreased DA and increased acetylcholine in NAcc [66]. 
Furthermore, Avena et al. [104] report increased anxiety in 
fasted rodents (36 h) that were previously maintained on an 
extended intermittent reinforcement schedule with 10 % 
sucrose solution. A similar withdrawal syndrome has been 
observed following 8 days of an intermittent access to sac-
charin [51]. It has also been demonstrated that rats on the 
intermittent access schedule show reduced D2 DA receptor 
binding in the DS [66].
A shared neurobiology?
An oft-repeated observation asserts that food and drug con-
sumption share a common neurobiology [105]. This is true 
in so far as drugs are understood to ‘hijack’ a neural system 
that primarily processes natural rewards like foods; how-
ever, important differences remain. First is the matter of 
the anatomical localisation of the neural circuits involved 
in these consummatory behaviours. Carelli et al. [106] 
have demonstrated that different populations of neurons in 
the NAcc respond to cocaine and natural rewards. Second, 
the dopaminergic response to sugar (and other foods) rap-
idly habituates, and it is attenuated by predictive cues such 
as smells; however, the DA response to cocaine does not 
habituate and is enhanced by predictive cues [31]. Third, 
when cue pairing to the delivery of either sugar or cocaine 
is established, the cue results in a dopaminergic surge. 
Importantly, in the case of sucrose, the DA level rapidly 
returns to baseline and does not rise again with lever press-
ing or consumption of sucrose [107] whereas in cocaine, 
the surge does not return to baseline but further increases 
after lever pressing and cocaine delivery [108]. Fourth, 
Pavlovian stimuli conditioned to food release DA in the 
NAcc core, whereas those conditioned to drugs of abuse 
release DA in the shell [54, 109].
Summary of the animal neuroscience
Clearly, addiction-like behaviours can be elicited by 
sucrose, but there are two important caveats to bear in mind. 
First, as evidenced by the studies using sucrose in sham-fed 
animals, and those that used real feeding with saccharin, it 
seems that these behaviours occur in response to the pal-
atability of sweet tastants, not the caloric content. Both of 
these findings raise another important question: Are there 
any pharmacodynamic effects of sucrose that are impor-
tant to the development of this addiction syndrome, in the 
way that pharmacodynamic effects of drugs are critical to 
the development of the neuroadaptive changes in addic-
tion? Second, these behaviours are only engendered in a 
specific intermittent access regime, which seems critical 
to their development, as these behaviours are not seen in 
animals given ad libitum access to sugar. Moreover, within 
this regime, test animals have been pre-selected for sucrose 
preference. This practice has become largely obsolete in 
animal models of drug addiction where drug-naïve animals 
are preferable. By excluding sucrose-naïve animals, the 
prevalence of addictive-like sucrose consumption remains 
unknown as opposed to cocaine or heroin addiction, where 
it has been estimated that between 5 and 24 % of individu-
als who use drugs go on to develop drug addiction [110–
112]. Clearly, the combination of sweet taste and inter-
mittent access can trigger a state that strongly resembles 
addiction in several aspects, including a cross-sensitisation 
effect to amphetamine and alcohol [68, 113] that seems to 
be mediated by mu-opioid receptor binding.
However, even in the intermittent access model, there 
remain several key deficiencies in the case for a sugar 
addiction. To date, increased motivation for sucrose has 
been poorly modelled because few studies have imple-
mented progressive ratio schedules to measure the rodents’ 
willingness to work for sugar. Rodents with extended 
access to sugar remain susceptible to devaluation pro-
cedures, such as the addition of a nausea-inducing agent, 
whereas cocaine- or heroin-addicted animals continue to 
pursue the drug despite negative consequences. The extent 
of habitual responding to sugar remains understudied, and 
the effect of CPP on reinstatement of sucrose seeking has 
yet to be characterised. In contrast, the presentation of 
conditioned stimuli reliably reinstates drug-seeking behav-
iours in animals with historic cocaine or heroin use, and 
the reinstatement of habitual drug seeking in response to 
environmental cues represents a hallmark feature of addic-
tion. Taken together, addictive-like consumption of sugar 
diverges from drug addiction on both neurobiological and 
behavioural levels, suggesting a need for great caution in 
drawing parallels between sugar and drug addiction.
Sugar addiction in humans
There has been little empirical work examining sugar 
addiction in humans. Given this, we consider how sugar 
addiction, as a specific form of FA, might be conceptualised 
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in humans, and we summarise experimental challenges in 
evaluating it, beginning with a brief overview of FA.
The behavioural phenotype of food addiction: the YFAS 
and YFAS 2.0
The current FA phenotype was first operationalised in the 
25-item Yale Food Addiction Scale (YFAS; [13]). Both 
the FA model and the YFAS conceptualised FA in terms 
of a translation of DSM-IV substance dependence [114] 
to food. Criteria include persistent eating despite nega-
tive consequences, persistent desire for food, unsuccess-
ful attempts to cut down and impairment of functioning 
because of overeating. The criteria are defined with respect 
to ‘certain foods’, and the YFAS provides 21 examples 
from 5 food categories: sweets (e.g. ice cream), starches 
(French fries), salty snacks (pretzels), fatty foods (pizzas), 
and sugary drinks. The YFAS can provide a ‘diagnosis’ of 
FA if at least three criteria are endorsed along with clinical 
impairment, or a ‘symptom count’ to indicate severity of 
symptomatology (scores range from 0 to 7). It has become 
a popular and widely used self-report measure of this con-
struct to the extent that it is used to both define and meas-
ure FA, though its validity and utility have been questioned 
[10, 11].
The YFAS has recently been updated [14] based on 
DSM-5 criteria for substance-related and addictive disor-
ders in the YFAS 2.0. The key difference is that, in updat-
ing criteria according to DSM-5, which incorporates both 
abuse and dependence, the threshold for diagnosing FA 
has been reduced. As such, individuals experiencing clini-
cally significant impairment may be diagnosed with mild 
(2–3 symptoms), moderate (4–5 symptoms), or severe (6 or 
more symptoms) FA. Preliminary validation of the YFAS 
2.0 estimates that 15.8 % of individuals meet criteria for 
FA, and 11.9 % of the sample met the threshold for severe 
FA. As with the YFAS, overweight and obese individu-
als endorsed more FA symptoms than their lean counter-
parts, and the prevalence rate of severe FA was highest in 
the obese weight class [14]. Although the authors report 
improved internal consistency and convergent validity 
in the YFAS 2.0, previously expressed concerns (see [11, 
115]) regarding the inclusion of withdrawal symptoms and 
tolerance and how they might relate to foods remain. With 
respect to these, the main concern is not that their presence 
is critical in FA; rather, their inclusion in the scale is under-
mined by the fact that they are not adequately defined and 
may therefore mean different things to different respond-
ents. Moreover, withdrawal is frequently endorsed by 
participants in several YFAS studies, and from the devel-
opment study of the YFAS 2.0, there seems to be strong 
concordance between the withdrawal items in the YFAS 
and the YFAS 2.0 [14]. It is important, therefore, that they 
are characterised clearly and rigorously. Given the lack of 
precise definition, it is difficult to determine conclusively 
that endorsement of this item reflects withdrawal symptoms 
to a particular nutrient or food. Indeed, if a withdrawal syn-
drome could be rigorously characterised, it would offer 
important clues as to the nature and mechanism of action 
of the addictive substance. However, here it is important to 
acknowledge the difficulty posed by the lack of a clearly 
defined addictive agent or food.
Does food addiction represent a distinct phenotype?
FA has several shared features and high levels of co-mor-
bidity with binge eating disorder (BED) [10, 116], which 
raises the question: could it be that YFAS is indirectly 
measuring a syndrome already well described as opposed 
to defining a distinct syndrome? BED is characterised by 
the consumption of objectively large portions of food with 
loss of control over eating, which is often done in iso-
lation and followed by feelings of guilt and disgust. It is 
associated with weight gain, but a significant proportion of 
people with BED are not obese. Patients with BED have 
been proposed to be the strongest candidates for FA [117], 
and some researchers have proposed that FA represents an 
atypical subtype of BED based on a growing body of the 
literature that has identified shared genetic vulnerabilities 
to drug abuse and binge eating. Others have suggested that 
individuals with BED exhibit poor impulse control and 
emotion regulation, as well as aberrant reward processing, 
which may increase FA liability [118]. Davis et al. [119] 
found that BED was associated with the A118 polymor-
phism of the mu-opioid receptor gene (OPRM1) and the 
Taq1A A1 polymorphism of the dopamine D2 receptor 
gene (DRD2), both risk factors for substance use disorder. 
This same group also identified a dopaminergic multilocus 
genetic profile that is uniquely associated with FA when 
controlling for binge eating behaviours [120]. These data 
suggest a similarity between FA and substance addictions, 
but require further exploration in well-powered studies with 
the appropriate diagnostic groups is necessary.
Long et al. [116] recently carried out the first system-
atic review of the YFAS literature. They examined 40 pub-
lished articles to address important outstanding questions 
about FA, including its relationship with BMI and eating 
disorder pathology and whether FA represents a distinct 
phenotype of disordered eating. The authors found a high 
co-occurrence of FA with BED and bulimia nervosa. An 
estimated 47.2 to 56.8 % of people with BED meet crite-
ria for a FA ‘diagnosis’ [116], and these prevalence rates 
seem excessive for a diagnostic subgroup. Binge eating 
frequency correlated with YFAS scores in both overweight 
and healthy weight groups, but the relationship with BMI 
was less clear-cut. Some studies report non-significant 
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differences in BMI across YFAS-diagnosed ‘food addicts’ 
and their healthy counterparts [121], while others indicate 
no correlation between BMI and YFAS score [122, 123]. 
While the prevalence rates of FA are consistently greater 
in overweight and obese groups (15.2 to 56.8 %), whether 
FA accounts for enough unique variance in obesity to be 
considered an explanatory mechanism for this condi-
tion remains unclear. Furthermore, the highest prevalence 
rates of FA have been reported in individuals with bulimia 
nervosa (83.6 %) [124, 125]. This finding should be inter-
preted cautiously as the numbers of individuals with diag-
nosed bulimia nervosa in these studies is small. Neverthe-
less, as these individuals often maintain a healthy BMI, it 
remains plausible that FA prevalence could be dissociable 
from BMI, particularly amongst those who have distorted 
thoughts related to food consumption. In summary, the 
findings of Long et al. [116] provide evidence of significant 
heterogeneity in the behavioural correlates of FA and sug-
gest poor discriminant validity of the YFAS.
Defining a sugar addiction in humans
Defining sugar addiction in humans remains challenging. 
First, as we have discussed earlier, little evidence supports 
sugar as an addictive substance, and the animal neurosci-
ence literature suggests sweetness or palatability to be criti-
cal elements of addictive-like eating. That is, sweet foods 
rather than sugar per se might be the ‘substance’ of inter-
est. Even so, there remain important questions about how 
sweetness or sugar content relates to addictive potential and 
whether sugar is necessary. Second, current measurement 
of FA is insufficiently precise, and given a commonplace 
behaviour like consumption of sweet food, it will be criti-
cal to define a profile of consumption that separates normal 
from disordered intake. The YFAS attempts to do this by 
using severity criteria for individual items and a necessary 
overall impairment criterion for diagnosis [13]. Although 
preliminary, examination of dietary profiles associated with 
problematic eating in young adults has shown that con-
sumption of energy-dense, nutrient-poor foods (e.g. candy, 
take out meals) is positively correlated with FA score and 
BMI [126]. Interestingly, dietary intake of carbohydrates or 
sugar was not significantly associated with FA diagnoses or 
scores, suggesting a limited role of sugar in putative addic-
tive-like eating in humans. Third, whether FA represents a 
distinct phenotype remains unclear, and the high degree of 
diagnostic overlap with BED is a particular difficulty. Dis-
tinguishing individuals with BED who preferentially binge 
on sweet foods from those with a sugar (or sweet food) 
addiction will be a challenging yet critical step towards a 
more refined FA phenotype.
An alternative approach would be to consider whether 
aspects of sugar or sweet food consumption share a 
similarity with addiction-like behaviours, such as crav-
ings (for a review, see [54]). The general population often 
reports food cravings, particularly for palatable foods like 
chocolate. However, these cravings differ from drug crav-
ings in terms of their intensity, their reported frequency 
and/or their duration. Food cravings are relatively short-
lived and subside with fasting as opposed to drug cravings, 
which persist and do not lessen in intensity with abstinence 
[54, 127]. Rogers and Smit [127] have proposed an alterna-
tive formulation: seeing food cravings in terms of ambiv-
alent attitudes to particular foods. Thus, for some people, 
chocolate is a highly desirable food but one that should be 
eaten with restraint. Attempts to restrain intake make choc-
olate more salient and preoccupying, and this is experi-
enced as a craving and hence, perhaps, likened to an addic-
tion. In part, this alternative approach asks whether there is 
an addictive aspect to normal eating (of sweet foods), and 
this is highly debatable.
Conclusions
In this perspective article, we have reviewed the current 
state of the evidence for sugar addiction. Most of the evi-
dence is limited to the animal neuroscience literature, and it 
is far from convincing. Importantly, several key elements of 
drug addiction have not been evaluated in sugar addiction 
models, such as the transition to compulsive drug-taking 
and dose-dependent effects on addiction liability. There 
remains a paucity of human evidence in this area, and we 
did not consider the literature encompassing the behav-
ioural and neural effects of sweet or palatable food con-
sumption as this would be far too indirect to the question of 
sugar addiction. There is the problem of the dearth of data 
on pure sugar consumption as we rarely consume sugar in 
isolation, and the ecological validity of studies examining 
pure sugar consumption in humans would be limited.
In terms of future directions, we suggest two areas of 
potential interest. The first is to examine whether sweet 
foods with high GI/GL might cause a food addiction in 
humans. We have discussed the significant methodologi-
cal and conceptual limitations of the human FA model and 
its measurement instruments, the YFAS and the YFAS 2.0, 
which will need to be considered in such explorations. The 
second is to examine the relevance of the intermittent sugar 
access schedule used in animal models to the development 
of eating disorders (and perhaps even a form of FA) in 
humans.
In summary, the science of sugar addiction at present 
is not compelling. Nevertheless, sugar addiction remains 
a very popular and powerful idea, but as this special issue 
illustrates, it is by no means alone in this regard when 
it comes to misconceptions about sugar. Even the most 
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perfunctory Internet search reveals how much emotive and 
explanatory power the term ‘sugar addiction’ has when 
used in its lay sense for individuals personally, as well as 
in the context of major public debates such as those over 
the sugar tax or campaigns such as Action on Sugar in 
the UK. Although the concept as we discuss it here is far 
more rigorous, the lay interpretation raises the question of 
whether sugar addiction is a useful (if not valid) concept to 
help tackle obesity and/or change the food environment? 
From a policy perspective, it is unlikely that sugar could 
be excluded from individuals’ diets given its presence in 
numerous food items, and any analogies suggested based on 
the regulation of illicit drugs would be specious. Given the 
multitude of interacting factors that increase one’s risk for 
eating disorders and obesity, we argue that support of sugar 
addiction as a primary causal mechanism of weight gain 
represents an extremely narrow view that fails to capture the 
complexity of these conditions, and one that may hamper 
more coordinated and appropriate responses. Furthermore, 
while there is a pressing need to address these important 
concerns, we argue that it is dangerous to draw strong con-
clusions about the validity of sugar addiction based on the 
current evidence. There are many strong arguments for cut-
ting down the consumption of sugar and reformulating food 
products accordingly, yet these arguments will all stand or 
fall according to the scientific case that supports them.
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